Dianthus Therapeutics (DNTH) Accumulated Depreciation & Amortization (2017 - 2025)
Dianthus Therapeutics (DNTH) has 6 years of Accumulated Depreciation & Amortization data on record, last reported at $250000.0 in Q2 2025.
- For Q2 2025, Accumulated Depreciation & Amortization changed N/A year-over-year to $250000.0; the TTM value through Jun 2025 reached $250000.0, changed N/A, while the annual FY2024 figure was $193000.0, 98.97% up from the prior year.
- Accumulated Depreciation & Amortization reached $250000.0 in Q2 2025 per DNTH's latest filing, up from $193000.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $250000.0 in Q2 2025 and bottomed at $30000.0 in Q4 2022.
- Average Accumulated Depreciation & Amortization over 4 years is $135666.7, with a median of $132000.0 recorded in 2023.
- Peak YoY movement for Accumulated Depreciation & Amortization: surged 223.33% in 2023, then soared 98.97% in 2024.
- A 4-year view of Accumulated Depreciation & Amortization shows it stood at $30000.0 in 2022, then soared by 223.33% to $97000.0 in 2023, then skyrocketed by 98.97% to $193000.0 in 2024, then rose by 29.53% to $250000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $250000.0 in Q2 2025, $193000.0 in Q4 2024, and $167000.0 in Q3 2024.